Emcure Pharmaceuticals Ltd (EMCURE) — Free Cash Flow Generation Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Free Cash Flow Generation Index of 0.50x as of September 2025. Free cash flow of Rs1.27 Billion represents 0% of operating cash flow (Rs2.56 Billion). See EMCURE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Emcure Pharmaceuticals Ltd Free Cash Flow Generation Index (2022–2026)
Historical FCF Generation Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. Explore EMCURE operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year Free Cash Flow Generation Index for Emcure Pharmaceuticals Ltd. For the full company profile including market capitalisation, see market value of Emcure Pharmaceuticals Ltd.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.58x | Rs4.90 Billion | Rs8.51 Billion | Rs3.61 Billion | ▲ +10.3% |
| 2025 | 0.52x | Rs4.45 Billion | Rs8.52 Billion | Rs4.07 Billion | ▼ -27.5% |
| 2024 | 0.72x | Rs7.90 Billion | Rs10.97 Billion | Rs3.07 Billion | ▲ +56.6% |
| 2023 | 0.46x | Rs3.43 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -4.8% |
| 2022 | 0.48x | Rs3.71 Billion | Rs7.68 Billion | Rs3.97 Billion | — |